Leading cancer doctors just wrapped up the annual European Society of Medical Oncology – or ESMO – meeting, where major breast cancer news was announced.
Kelsey Hampton, a research grants manager at Susan G. Komen, shares the results of three clinical trials – and what they could mean for patients.
Thanks to the hard work of clinicians and scientists, several new treatment options are on the horizon for patients with triple negative breast cancer, a subtype that is very hard to treat, and metastatic breast cancer, for which there is currently no cure.
